Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This is a minor administrative update to the page's versioning information and does not affect the study details or how the page functions.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a newer version of the page. This likely reflects internal updates or fixes and does not imply changes to the displayed study information.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the study page.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.3 is now shown on the page. The previous revision label v3.4.2 has been removed.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.